Inhibitor von:
2900008C10Rik, AEBP2, AHDC1, ANKRD24, ASH1L, AU022751, BAF53B, BAF57, BPTF, BRWD3, CHD (chromodomain helicase), CHD2, CHD5, CHD9, DBC1, DOT1L1, DPF3, DPY-30, EG236663, EG333452, EG434797, EG546205, ENX-2, EPC1, EPC2, Evi-1, EZHIP, FAM136A, GLT8D3, His-probe, Histone cluster 1 H2AA, Histone cluster 1 H2AB, Histone cluster 1 H2AE, Histone cluster 1 H2AH, Histone cluster 1 H2AI, Histone cluster 1 H2AJ, Histone cluster 1 H2AK, Histone cluster 1 H2AL, Histone cluster 1 H2AM, Histone cluster 1 H2BA, Histone cluster 1 H2BB, Histone cluster 1 H2BC, Histone cluster 1 H2BE, Histone cluster 1 H2BF, Histone cluster 1 H2BG, Histone cluster 1 H2BH, Histone cluster 1 H2BI, Histone cluster 1 H2BJ, Histone cluster 1 H2BL, Histone cluster 1 H2BM, Histone cluster 3 H2BB, Histone cluster 3 H3, Histone H2B, hIws1, L3MBTL2, LMCD1, MacroH2A2, Mael, Med17, Menin, MLLT (Mixed Lineage Leukemia Translocated), MSL-1, MSL3L2, N6AMT2, NBR1, NSD1, Obox3, Olfr549, Paf1, PCGF5, PCGF6, PEG3, PHC1, PHC2, PHC3, PHF1, PHF19, Polycomb, PRDM16, PRDM7, RACK7, RbAp46, RCOR2, RIG-I, SAMD4A, Set2, SmcX, Snf2, TADA2L, TAF9A, TRIM12, Trimethyl Histone H3, TSPYL4, ZMYND17, ZNF197, ZNF198, ZNF250, ZNF251, ZNF274, ZNF334, ZNF337, ZNF34, ZNF341, ZNF343, ZNF430, ZNF434, ZNF445, ZNF502, ZNF508, ZNF519, ZNF532, ZNF572, ZNF619, ZNF621, ZNF623, ZNF764, ZSCAN1, und ZSCAN4D.